{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:07:40Z","timestamp":1759334860365,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.jaad.2011.09.007","type":"journal-article","created":{"date-parts":[[2011,12,15]],"date-time":"2011-12-15T06:25:13Z","timestamp":1323930313000},"page":"148-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Time for a change? Updated guidelines using interferon gamma release assays for detection of latent\u00a0tuberculosis infection in the office setting"],"prefix":"10.1016","volume":"66","author":[{"given":"Marisa","family":"Kardos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexa Boer","family":"Kimball","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2011.09.007_bib1","first-page":"1","article-title":"Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection\u2013United States, 2010","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaad.2011.09.007_bib2","unstructured":"Centers for Disease Control and Prevention. The difference between latent TB infection and active TB disease; March 2010.\u00a0Available from: URL:http:\/\/www.cdc.gov\/tb\/publications\/factsheets\/general\/LTBIandActiveTB.htm. Accessed July 18, 2011."},{"key":"10.1016\/j.jaad.2011.09.007_bib3","first-page":"CD008794","article-title":"Adverse effects of biologics: a network meta-analysis and Cochrane overview","volume":"2","author":"Singh","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2011.09.007_bib4","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor \u03b1-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2011.09.007_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/bmb\/ldp039","article-title":"100 year update on diagnosis of tuberculosis infection","volume":"93","author":"Lalvani","year":"2010","journal-title":"Br Med Bull"},{"key":"10.1016\/j.jaad.2011.09.007_bib6","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1378\/chest.09-2350","article-title":"Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a meta-analysis","volume":"137","author":"Diel","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jaad.2011.09.007_bib7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/1471-2334-9-207","article-title":"Performance of the tuberculin skin test and interferon-gamma release assay in immunocompromised patients in a BCG-vaccinated population","volume":"9","author":"Kim","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jaad.2011.09.007_bib8","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1469-0691.2011.03555.x","article-title":"Guidelines on interferon-\u03b3 release assays for tuberculosis infection: concordance, discordance or confusion?","volume":"17","author":"Denkinger","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jaad.2011.09.007_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000222431","article-title":"Tuberculin skin test overestimates tuberculosis hypersensitivity in adult patients with psoriasis","volume":"219","author":"Tsiouri","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2011.09.007_bib10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jaad.2008.03.023","article-title":"National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents","volume":"59","author":"Doherty","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2011.09.007_bib11","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1468-3083.2010.03836.x","article-title":"Incidence of tuberculosis infection in psoriatic patients on anti\u2013TNF therapy: report of a case series with 144 patients","volume":"25","author":"S\u00e1nchez-Moya","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2011.09.007_bib12","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1473-3099(03)00545-0","article-title":"Antitumor necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management","volume":"3","author":"Gardam","year":"2003","journal-title":"Lancet Infect Dis"},{"year":"2010","series-title":"Remicade (infliximab) for intravenous injection [prescribing information]","key":"10.1016\/j.jaad.2011.09.007_bib13"},{"year":"2010","series-title":"Humira (adalimumab) for subcutaneous injection [prescribing information]","key":"10.1016\/j.jaad.2011.09.007_bib14"},{"year":"2010","series-title":"Enbrel (etanercept) for subcutaneous injection [prescribing information]","key":"10.1016\/j.jaad.2011.09.007_bib15"},{"key":"10.1016\/j.jaad.2011.09.007_bib16","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/383317","article-title":"Granulomatous infectious diseases associated with tumor necrosis factor antagonists","volume":"38","author":"Wallis","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2011.09.007_bib17","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/art.22768","article-title":"Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection","volume":"57","author":"Gomez-Reino","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2011.09.007_bib18","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2133.2009.09331.x","article-title":"Tuberculosis screening in patients with psoriasis before antitumor necrosis factor therapy: comparison of an interferon-\u03b3 release assay vs tuberculin skin test","volume":"161","author":"Laffitte","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2011.09.007_bib19","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s10096-008-0519-1","article-title":"Performance of two commercial blood IFN-\u03b3 release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti\u2013TNF-\u03b1 treatment","volume":"27","author":"Bocchino","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jaad.2011.09.007_bib20","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1365-2133.2008.08457.x","article-title":"QuantiFERON-TB Gold testing for tuberculosis in psoriasis patients commencing anti\u2013tumor necrosis factor \u03b1 therapy","volume":"158","author":"Desai","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2011.09.007_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/ard.2008.101857","article-title":"Comparison of interferon {gamma} release assays and conventional screening tests before tumor necrosis factor {alpha} blockade in patients with inflammatory arthritis","volume":"69","author":"Martin","year":"2010","journal-title":"Ann Rheum Dis"},{"year":"2008","series-title":"Tuberculosis: clinical diagnosis and management of tuberculosis and measure for its prevention and control","key":"10.1016\/j.jaad.2011.09.007_bib22"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962211010486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962211010486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:20:37Z","timestamp":1759270837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962211010486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0190962211010486"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2011.09.007","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Time for a change? Updated guidelines using interferon gamma release assays for detection of latent\u00a0tuberculosis infection in the office setting","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2011.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}